We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLDP icon
2776
Solid Power
SLDP
$532M
$347K ﹤0.01%
210,049
+5,587
+3% +$9.64K
FMS icon
2777
Fresenius Medical Care
FMS
$12.9B
$345K ﹤0.01%
18,067
+1,128
+7% +$23K
QUAD icon
2778
Quad
QUAD
$525M
$344K ﹤0.01%
63,040
-2,295
-4% -$11.3K
CIO
2779
DELISTED
City Office REIT
CIO
$343K ﹤0.01%
68,975
+3,299
+5% +$15.9K
INZY
2780
DELISTED
Inozyme Pharma
INZY
$343K ﹤0.01%
77,004
+13,867
+22% +$67.2K
EVCM icon
2781
EverCommerce
EVCM
$1.93B
$343K ﹤0.01%
31,248
-494
-2% -$4.77K
CTOS icon
2782
Custom Truck One Source
CTOS
$2.37B
$341K ﹤0.01%
78,388
+1,665
+2% +$8.11K
CPS icon
2783
Cooper-Standard Automotive
CPS
$558M
$340K ﹤0.01%
27,353
+3,723
+16% +$53.4K
STRO icon
2784
Sutro Biopharma
STRO
$421M
$340K ﹤0.01%
11,610
+2,194
+23% +$86.8K
BLFY
2785
DELISTED
Blue Foundry Bancorp
BLFY
$339K ﹤0.01%
37,394
-1,267
-3% -$11.3K
IAUX
2786
i-80 Gold Corp
IAUX
$1.4B
$339K ﹤0.01%
313,819
+60,343
+24% +$70.8K
CDXS icon
2787
Codexis
CDXS
$158M
$337K ﹤0.01%
108,594
+4,017
+4% +$12.9K
FLIC
2788
DELISTED
First of Long Island Corp
FLIC
$335K ﹤0.01%
33,419
+1,231
+4% +$12.5K
TELN
2789
DELISTED
TELENOR ASA
TELN
$334K ﹤0.01%
29,415
-7,627
-21% -$86.6K
MVBF icon
2790
MVB Financial
MVBF
$389M
$333K ﹤0.01%
17,888
+549
+3% +$10.5K
ALXO icon
2791
ALX Oncology
ALXO
$290M
$333K ﹤0.01%
55,220
+5,360
+11% +$65.9K
CBAN icon
2792
Colony Bankcorp
CBAN
$467M
$333K ﹤0.01%
27,156
+641
+2% +$7.29K
REI icon
2793
Ring Energy
REI
$339M
$332K ﹤0.01%
196,408
+24,993
+15% +$46K
ABSI icon
2794
Absci
ABSI
$1.51B
$331K ﹤0.01%
107,324
+104,648
+3,911% +$485K
ONTF
2795
DELISTED
ON24
ONTF
$329K ﹤0.01%
54,726
-2,913
-5% -$18.5K
LUNG icon
2796
Pulmonx
LUNG
$87.6M
$328K ﹤0.01%
51,706
-936
-2% -$7.2K
REP
2797
DELISTED
REPSOL YPF SA ADS(RP 1 CAP SH)
REP
$328K ﹤0.01%
20,836
+3,771
+22% +$59.3K
BIDU icon
2798
Baidu
BIDU
$37.2B
$327K ﹤0.01%
3,785
-407
-10% -$40.9K
FDBC icon
2799
Fidelity D&D Bancorp
FDBC
$317M
$327K ﹤0.01%
7,465
+259
+4% +$11.9K
SGC icon
2800
Superior Group of Companies
SGC
$225M
$326K ﹤0.01%
17,252
+16,662
+2,824% +$307K

Similar funds

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.